Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

72°
- Kane, PA (16735)
  Today
  
  Rain showers this evening with overcast skies overnight. Areas of patchy fog. Low around 60F. Winds light and variable. Chance of rain 50%..
  
  Tonight
  
  Rain showers this evening with overcast skies overnight. Areas of patchy fog. Low around 60F. Winds light and variable. Chance of rain 50%.
  
  Updated: September 17, 2026 @ 6:25 pm
- Full Forecast

Site search

Home
News
Sports
Obituaries
Local Events
- Promote Your Event
Photos
e-Edition
Classifieds
- Place an ad
Archives
Turkey Contest
Best of 2026

Recent Quotes

View Full List

My Watchlist

Create Watchlist

Indicators

Dow Jones Industrial Average

Markets:

Overview

News

Currencies

International

Treasuries

Candel Therapeutics, Inc. - Common Stock (NQ:CADL)

8.290 +0.040 (+0.48%)

Delayed Quote Updated: 9:33 AM EDT, Oct 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Candel Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Candel Therapeutics Sets Path to Success: Recent Achievements Pave the Way for a Promising 2024 Propelled by Key Value Drivers and Catalysts

February 05, 2024

From Candel Therapeutics

Via GlobeNewswire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

December 18, 2023

It's time to start the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Monday morning!

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

December 13, 2023

Via Benzinga

Recap: Candel Therapeutics Q3 Earnings ↗

November 09, 2023

Via Benzinga

Why Johnson Controls International Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

December 12, 2023

Shares of Johnson Controls International plc (NYSE: JCI) moved lower during Tuesday’s session following weak quarterly results.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

December 12, 2023

Via Benzinga

US Stocks Edge Lower; Inflation Rate Slows to 3.1% In November ↗

December 12, 2023

U.S. stocks traded slightly lower this morning, following the release of inflation data on Tuesday. Following the market opening Tuesday, the Dow traded down 0.04% to 36,389.01 while the NASDAQ fell...

Via Benzinga

Topics Economy Stocks

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

December 12, 2023

Via Benzinga

Candel Therapeutics Receives FDA Fast Track Designation for CAN-2409 in Pancreatic Cancer

December 12, 2023

From Candel Therapeutics

Via GlobeNewswire

Candel Therapeutics Announces Restructuring to Prioritize Resources on Key Value Drivers for Expanded Development of CAN-3110, the enLIGHTEN™ Discovery Platform, and Key Clinical Readouts for CAN-2409

November 28, 2023

From Candel Therapeutics

Via GlobeNewswire

Candel Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights

November 09, 2023

From Candel Therapeutics

Via GlobeNewswire

Why Is Cancer Player Candel Therapeutics Stock Trading Higher Today? ↗

November 06, 2023

Candel Therapeutics Inc (NASDAQ: CADL) released initial interim survival and immunological biomarker data from the ongoing phase 2 trial of CAN-2409 plus valacyclovir (prodrug) together with standard...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 06, 2023

Via Benzinga

Candel Therapeutics Presents Preclinical Data from its enLIGHTEN™ Discovery Platform at SITC

November 04, 2023

From Candel Therapeutics

Via GlobeNewswire

Candel Therapeutics Announces Initial Positive Interim Data from Randomized Phase 2 Clinical Trial of CAN-2409 in Non-Metastatic Pancreatic Cancer

November 03, 2023

From Candel Therapeutics

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 18, 2023

Via Benzinga

Candel Therapeutics Announces Nature Publication Showing Extended Survival Associated with Immune Activation in Patients with Recurrent High-Grade Glioma Treated with CAN-3110

October 18, 2023

From Candel Therapeutics

Via GlobeNewswire

Candel Therapeutics Announces Three Abstracts Accepted for Poster Presentations at SITC 2023 Annual Meeting

September 27, 2023

From Candel Therapeutics

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 26, 2023

Via Benzinga

Candel Therapeutics Reveals Early Survival Data From Lung Cancer Trial ↗

September 26, 2023

Candel Therapeutics Inc (NASDAQ: CADL) announced updated activity data from its ongoing, open-label, phase 2 trial of CAN-2409 plus valacyclovir in combination with continued immune checkpoint...

Via Benzinga

Candel Therapeutics Reports Encouraging Initial Survival Data from Phase 2 Clinical Trial of CAN-2409 in Non-Small Cell Lung Cancer

September 26, 2023

From Candel Therapeutics

Via GlobeNewswire

Candel Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference

September 06, 2023

From Candel Therapeutics

Via GlobeNewswire

Candel Therapeutics Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights

August 10, 2023

From Candel Therapeutics

Via GlobeNewswire

Candel Therapeutics to Participate in the Canaccord Genuity 43rd Annual Growth Conference

August 02, 2023

From Candel Therapeutics

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Wednesday ↗

July 26, 2023

Wednesday saw 59 companies set new 52-week lows.

Via Benzinga

Why ToughBuilt Industries Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

June 21, 2023

Gainers Advanced Health Intelligence Ltd. (NASDAQ: AHI) shares jumped 209.5% to $2.29 after the company signed a Letter of Intention with UAE-Based e-script medicine management company Pharmak...

Via Benzinga

Candel Therapeutics Announces It Expects to Report Topline Data from its Phase 2 Clinical Trial of CAN-2409 in Non-Small Cell Lung Cancer in the Second Quarter of 2024

June 13, 2023

From Candel Therapeutics

Via GlobeNewswire

Candel Therapeutics Appoints Experienced Manufacturing Leader Nicoletta Loggia, PhD, RPh to its Board of Directors

June 08, 2023

Nicoletta Loggia, PhD, RPh, biopharma executive with more than two decades of technical expertise in the biopharmaceutical industry

From Candel Therapeutics

Via GlobeNewswire

Candel Therapeutics to Participate in the 2023 Jefferies Healthcare Conference

June 05, 2023

From Candel Therapeutics

Via GlobeNewswire

Candel Therapeutics Says One Dose Of CAN-3110 Shows Encouraging Responses In A Type Of Brain Cancer ↗

May 19, 2023

Candel Therapeutics Inc (NASDAQ: CADL) announced new data from an ongoing phase 1 trial of its herpes simplex virus-1 (HSV-1) replication-competent viral immunotherapy candidate, CAN-3110, in patients...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Entertainment
Local Events
Obituaries
Multimedia
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

The Kane Republican

KaneRepublican.com
200 North Fraley
Kane, PA 16735
Phone: 814-837-6000
Email: krnews1@zitomedia.net

Facebook

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Kane, PA (16735)

Today

Tonight

Candel Therapeutics, Inc. - Common Stock (NQ:CADL)

All News about Candel Therapeutics, Inc. - Common Stock

Sections

Services

The Kane Republican